In conclusion, our study demonstrates that CACNA1B (Cav2.2) plays a role in the development of NSCLC and CACNA1B (Cav2.2) overexpression is an independent prognostic marker for NSCLC in Chinese population. This evidence concerns the gene CACNA1B and non-small cell lung carcinoma.